Be an early applicantLess than 25 applicants
This job has closed.
Amgen · 3 days ago
Process Development Senior Principal Scientist
Thousand Oaks, CA
Full-time
Hybrid
Senior Level
10+ years exp
Wonder how qualified you are to the job?
Maximize your interview chancesBiotechnologyHealth Care
Insider Connection @Amgen
Responsibilities
Oversight of late-stage biologics drug product formulation and fill/finish process development.
Lead cross-functional Drug Product Commercialization Teams for pipeline and lifecycle management projects.
Engage in planning, design, execution, and documentation of formulation and fill/finish process development studies.
Manage and expand core product-enabling platform knowledge assets.
Collaborate with teams to ensure platforms align with product needs.
Provide guidance and best practices to product teams on platform capabilities.
Measure portfolio performance against platform targets.
Manage a team of engineers and scientists.
Author and review technical documents and regulatory sections.
Drive continuous improvement in drug product development process.
Serve as subject matter expert in drug product technologies.
Deliver progress reports and presentations.
Travel domestically and internationally as needed.
Qualification
Find out how your skills align with this job's requirements. If anything seems off, you can easily click on the tags to select or unselect skills to reflect your actual expertise.
Required
Bachelor’s degree and 8 years of Scientific experience OR
Master’s degree and 6 years of Scientific experience OR
Doctorate degree PhD OR PharmD OR MD [and relevant post-doc where applicable] and 3 years of Scientific experience
Preferred
Advanced degree in Engineering, Pharmaceutics, Biotechnology or Material Science.
10+ years of post-PhD experience including elements of formulation and fill/finish process development, process characterization, technical transfers to manufacturing sites, and statistical design and analysis of experiments, and regulatory authoring.
Leadership of highly technical professionals with demonstrated results driving forward pipeline and lifecycle management programs.
Hands-on experience bringing new biotech products to market, across various dosage forms and device delivery systems.
Experience with advanced drug delivery for biologics including sustained release, nasal, pulmonary, or dermal delivery.
Outstanding knowledge of formulation, aseptic processing and manufacturing of biotechnology products, vials, syringes, cartridges, devices, disposables, modeling, and the associated GMP/Device documentation and regulatory filings.
Strong problem solving and effective cross-functional communication skills and ability to influence colleagues with ideas.
Previous scientific and managerial experience in support of drug product development, investigations and regulatory filing.
Ability to learn and act on dynamic information at a rapid pace.
Demonstrated track record of publication, patents and presentations.
Benefits
Comprehensive employee benefits package, including a Retirement and Savings Plan with generous company contributions, group medical, dental and vision coverage, life and disability insurance, and flexible spending accounts.
A discretionary annual bonus program, or for field sales representatives, a sales-based incentive plan
Stock-based long-term incentives
Award-winning time-off plans and bi-annual company-wide shutdowns
Flexible work models, including remote work arrangements, where possible
Company
Amgen
Amgen is a biotechnology company that develops and manufactures human therapeutics for various illnesses and diseases.
10,001+ employees
H1B Sponsorship
Amgen has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Trends of Total Sponsorships
2023 (349)
2022 (523)
Funding
Current Stage
Public CompanyTotal Funding
$28.5B2022-12-12Post Ipo Debt· $28.5B
1983-06-24IPO· nasdaq:AMGN
Leadership Team
Robert Bradway
Chairman and Chief Executive Officer
Judy Brown
SVP Corporate Affairs
Recent News
2024-06-05
MarketScreener
2024-06-05
Company data provided by crunchbase
